Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
IUBMB CommentsThis eukaryotic enzyme recognizes the sequence -Arg-Arg-X-Ser*/Thr*-Hpo, where * indicates the phosphorylated residue and Hpo indicates a hydrophobic residue.The inactive holoenzyme is a heterotetramer composed of two regulatory (R) subunits and two catalytic (C) subunits. Each R subunit occludes the active site of a C subunit and contains two binding sites for 3',5'-cyclic-AMP (cAMP). Binding of cAMP activates the enzyme by causing conformational changes that release two free monomeric C subunits from a dimer of the R subunits, i.e. R2C2 + 4 cAMP = R2(cAMP)4 + 2 C. Activity requires phosphorylation of a conserved Thr in the activation loop (T-loop) sequence (Thr198 in human Calpha; Thr224 in budding yeast Tpk2), installed by auto-phosphorylation or by the 3-phosphoinositide-dependent protein kinase-1 (PDPK1). Certain R2C2 combinations can be localized to particular subcellular regions by their association with diverse species of 'A Kinase-Anchoring Proteins' (AKAPs). The enzyme has been characterized from many organisms. Humans have three C units (Calpha, Cbeta, and Cgamma) encoded by the paralogous genes PRKACA, PRKACB and PRKACG, respectively, and four R subunits (R1alpha, RIbeta, RIIalpha and RIIbeta), encoded by PKRAR1A, PKRAR1B, PKRAR2A and PKRAR2B, respectively. Yeast (Saccharomyces cerevisiae) has three C subunits (Tpk1, Tpk2, and Tpk3) encoded by the paralogous genes TPK1, TPK2 and TPK3, respectively, and a single R subunit (Bcy1) encoded by the BCY1 gene. Some validated substrates of the enzyme include cAMP-response element-binding protein (CREB), phosphorylase kinase alpha subunit (PHKA), and tyrosine 3-monooxygenase (TH) in mammals; Adr1, Whi3, Nej1, and Pyk1 in yeast.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP + BKCa channel ZERO
ADP + phosphorylated BKCa channel ZERO
-
recombinant murine HA-tagged tetrameric protein expressed in HEK-293 cells, phosphorylation at Ser899 activates the channel
-
-
?
ATP + G protein-coupled receptor GRK1
ADP + phosphorylated G protein-coupled receptor GRK1
ATP + G protein-coupled receptor GRK7
ADP + phosphorylated G protein-coupled receptor GRK7
ATP + Kemptide
ADP + Kemptide phosphate
ATP + Kemptide
ADP + phosphorylated Kemptide
-
activity of catalytic PKA subunit
-
-
?
ATP + Leu-Arg-Arg-Ala-Ser-Leu-Gly
ADP + Leu-Arg-Arg-Ala-phospho-Ser-Leu-Gly
-
commercial artificial heptapeptide substrate kemptide
-
-
?
ATP + N-(8-([4-[3-(ethoxycarbonyl)-6,8,8-trimethyl-2-oxo-7,8-dihydro-2H-pyrano[3,2-g]quinolin-9(6H)-yl]butanoyl]amino)octanoyl)-GRTGRRFSYP-amide
ADP + N-(8-([4-[3-(ethoxycarbonyl)-6,8,8-trimethyl-2-oxo-7,8-dihydro-2H-pyrano[3,2-g]quinolin-9(6H)-yl]butanoyl]amino)octanoyl)-GRTGRRFpSYP-amide
-
-
-
-
?
ATP + N-(8-([[7-(diethylamino)-2-oxo-2H-chromen-3-yl]carbonyl]amino)octanoyl)-GRTGRRFSYP-amide
ADP + N-(8-([[7-(diethylamino)-2-oxo-2H-chromen-3-yl]carbonyl]amino)octanoyl)-GRTGRRFpSYP-amide
-
-
-
-
?
ATP + N-(8-[[(11-oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-10-yl)carbonyl]amino]octanoyl)-GRTGRRFSYP-amide
ADP + N-(8-[[(11-oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-10-yl)carbonyl]amino]octanoyl)-GRTGRRFpSYP-amide
-
-
-
-
?
ATP + NDUFS-4 protein
ADP + phosphorylated NDUFS-4 protein
-
-
-
-
?
ATP + NF-kappaB p65
ADP + phoshorylated NF-kappaB p65
-
phosphorylation by the catalytic subunit of PKA
-
-
?
ATP + small heat shock-related protein HSP20
ADP + phosphorylated small heat shock-related protein HSP20
-
-
-
-
?
ATP + tyrosine hydroxylase
ADP + phosphorylated tyrosine hydroxylase
-
activity of catalytic PKA subunit
-
-
?
additional information
?
-
ATP + G protein-coupled receptor GRK1
ADP + phosphorylated G protein-coupled receptor GRK1
-
-
-
-
?
ATP + G protein-coupled receptor GRK1
ADP + phosphorylated G protein-coupled receptor GRK1
-
recombinant FLAG-tagged GRK1, phosphorylation at Ser21
-
-
?
ATP + G protein-coupled receptor GRK7
ADP + phosphorylated G protein-coupled receptor GRK7
-
-
-
-
?
ATP + G protein-coupled receptor GRK7
ADP + phosphorylated G protein-coupled receptor GRK7
-
recombinant FLAG-tagged GRK7, phosphorylation at Ser23 and Ser36
-
-
?
ATP + Kemptide
ADP + Kemptide phosphate
-
-
-
-
?
ATP + Kemptide
ADP + Kemptide phosphate
-
catalytic subunit C
-
-
?
ATP + Kemptide
ADP + Kemptide phosphate
-
LRRASLG peptide substrate, activity of the catalytic subunit C
-
-
?
additional information
?
-
-
regulation of GRK1 and GRK7 by cAMP level during light and dark phases
-
-
?
additional information
?
-
-
cAMP binds to the helical subunit C binding regions relayed by the highly dynamic switch of the C-helix of subunit RIalpha, which is linked to cAMP by a salt bridge essential for activation
-
-
?
additional information
?
-
-
substrates have differential effects on type I and type II PKA holoenzyme dissociation, the isolated catalytic subunit is catalytically active
-
-
?
additional information
?
-
-
the regulatory subunit of PKA inhibits its kinase activity by shielding the catalytic subunit from physiological substrates, Asp170 not only plays a pivotal role in controlling the local conformation of the phosphate binding cassette, where cAMP docks, but also significantly affects the long-range cAMP-dependent interaction network that extends from the phosphate binding cassette to the three major sites of C-recognition
-
-
?
additional information
?
-
-
complex I subunit ESSS is not phosphorylated by PKA
-
-
?
additional information
?
-
-
development of kinase activity sensor fluorogenic substrates, upon phosphorylation the peptide interacts with a phosphoserine-binding protein 14-3-3 domain, displacing the quencher, and resulting in a burst of fluorescence, overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(Rp)-adenosine 3',5'-cyclic monophosphothioate
-
i.e. (Rp)-cAMPS, analogue of cAMP, competitive inhibition of PKA activation by cAMP, binding site structure
(Sp)-adenosine 3',5'-cyclic monophosphothioate
-
i.e. (Sp)-cAMPS, analogue of cAMP, competitive inhibition of PKA activation by cAMP, binding site structure
Acetylsalicylic acid
-
a non-steroidal anti-inflammatory drug, decreases adrenaline- or dibutyryl cAMP-stimulated glycerol release in isolated adipocytes
alsterpaullone
-
21% inhibition of CDK2 at 0.01 mM
H2O2
-
H2O2 inhibits activation of PKA, but inhibition can be reverted with dithiothreitol or with thioredoxin reductase plus thioredoxin, H2O2 is ineffective if the PKA holoenzyme is preincubated with cAMP, if added to the catalytic alpha-subunit, which is active independently of cAMP activation, or if the catalytic alpha-subunit is substituted by ist C199A mutant in the reconstituted holoenzyme
indirubin-3'-monoxime
-
20% inhibition of CDK2 at 0.01 mM
naproxen
-
a non-steroidal anti-inflammatory drug, decreases adrenaline- or dibutyryl cAMP-stimulated glycerol release in isolated adipocytes
nimesulide
-
a non-steroidal anti-inflammatory drug, decreases adrenaline- or dibutyryl cAMP-stimulated glycerol release in isolated adipocytes
piroxicam
-
a non-steroidal anti-inflammatory drug, decreases adrenaline- or dibutyryl cAMP-stimulated glycerol release in isolated adipocytes
purvalanol
-
18% inhibition of CDK2 at 0.01 mM
roscovitine
-
7% inhibition of CDK2 at 0.01 mM
H-89
-
-
H-89
-
permeant inhibitor of PKA
additional information
modification and concomitant inactivation of the catalytic subunit of bovine heart cAMP-dependent protein kinase with affinity analogs of peptide substrates potentially capable of undergoing disulfide interchange with enzyme-bound sulfhydryl groups
-
additional information
-
modification and concomitant inactivation of the catalytic subunit of bovine heart cAMP-dependent protein kinase with affinity analogs of peptide substrates potentially capable of undergoing disulfide interchange with enzyme-bound sulfhydryl groups
-
additional information
-
no inhibition of CDK2 by kenpaullone
-
additional information
-
the regulatory subunits competitively inhibit the PKA kinase activity
-
additional information
-
cyclo-oxygenase-independent inhibitory effect of non-steroidal anti-inflammatory drugs, mechanism, overview
-
additional information
-
alpha2A-adrenoceptor stimulation with brimonidine inhibits PKA activity via inhibition of adenylyl cyclase
-
additional information
-
the C subunit is inactivated by Zn2+-metalloprotease-mediated proteolysis
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
calpain
-
activates the PKA holoenzyme in a cAMP-independent fashion. A variety of agents, including inhibitors of the electron transport chain, activate calpain in a Ca2+-dependent manner, which, in turn, catalyzes the proteolysis of the R subunit, thereby releasing the C subunit in its active form, overview
-
forskolin
-
activation at 0.01 mM
isoproterenol
-
activation at 0.001 mM
cAMP
-
-
cAMP
-
dependent on, activates the enzyme by partly dissociating the regulatory and the catalytic subunits, determination and analysis of the mechanism, the substrate plays a differential role in activation of type I versus type II holoenzyme
cAMP
-
dependent on, binding site
cAMP
-
dependent on, competitive to regulatory subunit RIalpha, at low concentration the activation of PKA type I, but not of PKA type II, by cAMP is accelerated by the peptide or protein substrate by increased dissociation of subunits Calpha and RIalpha, cAMP has low effect on RII/PKA type II, overview
cAMP
-
dynamics of the binding domain structure, molecular binding mechanism, overview
cAMP
-
activation of protein kinase A involves the synergistic binding of cAMP to two cAMP binding sites on the inhibitory R subunit, causing release of the C subunit, which subsequently can carry out catalysis
cAMP
-
exposure of mitochondria to cAMP results in enhanced catalytic subunit catalytic activity. Upon binding of cAMP to the regulatory subunits, the catalytic subunits are released and are thus free to catalyze the phosphorylation of an array of proteins, But cAMP fails to promote R subunit degradation by beta-catenin
dibutyryl-cAMP
-
-
dibutyryl-cAMP
-
activates in vitro
additional information
-
beta-adrenergic stimulation with isoprenaline leads to activation of PKA via stimulation of adenylyl cyclase
-
additional information
-
oligomycin, antimycin A, rotenone, CCCP, sodium azide, or Ca2+ activate calpain which activates the cAMP-dependent protein kinase
-
additional information
-
treatment of mitochondria with electron transport chain inhibitors rotenone, antimycin A, sodium azide, and oligomycin, as well as an uncoupler of oxidative phosphorylation, elicits enhanced C subunit activity. The catalytic subunit can exist in an inactive state via association with IkappaB in an NF-kappaB-IkappaB-(C subunit) complex. Stimulation of cells with lipopolysaccharide, endotheln-1, or angiotensin II induces IkappaB degradation, resulting in the ensuing C subunit-catalyzed phosphorylation of NF-kappaB p65
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Bramson, H.N.; Thomas, N.; Matsueda, R.; Nelson, N.C.; Taylor, S.S.; Kaiser, E.T.
Modification of the catalytic subunit of bovine heart cAMP-dependent protein kinase with affinity labels related to peptide substrates
J. Biol. Chem.
257
10575-10581
1982
Bos taurus (P00517), Bos taurus
brenda
Engh, R.A.; Girod, A.; Kinzel, V.; Huber, R.; Bossemeyer, D.
Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity
J. Biol. Chem.
271
26157-26164
1996
Bos taurus (P00517)
brenda
Prade, L.; Engh, R.A.; Girod, A.; Kinzel, V.; Huber, R.; Bossemeyer, D.
Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential
Structure
5
1627-1637
1997
Bos taurus (P00517)
brenda
Shoji, S.; Ericsson, L.H.; Walsh, K.A.; Fischer, E.H.; Titani, K.
Amino acid sequence of the catalytic subunit of bovine type II adenosine cyclic 3',5'-phosphate dependent protein kinase
Biochemistry
22
3702-3709
1983
Bos taurus (P00517)
brenda
Shoji, S.; Parmelee, D.C.; Wade, R.D.; Kumar, S.; Ericsson, L.H.; Walsh, K.A.; Neurath, H.; Long, G.L.; Demaille, J.G.; Fischer, E.H.; Titani, K.
Complete amino acid sequence of the catalytic subunit of bovine cardiac muscle cyclic AMP-dependent protein kinase
Proc. Natl. Acad. Sci. USA
78
848-851
1981
Bos taurus (P00517), Bos taurus
brenda
Wiemann, S.; Kinzel, V.; Pyerin, W.
Cloning of the C alpha catalytic subunit of the bovine cAMP-dependent protein kinase
Biochim. Biophys. Acta
1171
93-96
1992
Bos taurus (P05131), Bos taurus
brenda
Showers, M.O.; Maurer, R.A.
A cloned bovine cDNA encodes an alternate form of the catalytic subunit of cAMP-dependent protein kinase
J. Biol. Chem.
261
16288-16291
1986
Bos taurus (P05131), Bos taurus
brenda
Bain, J.; McLauchlan, H.; Elliott, M.; Cohen, P.
The specificities of protein kinase inhibitors: an update
Biochem. J.
371
199-204
2003
Bos taurus
brenda
Vigil, D.; Blumenthal, D.K.; Brown, S.; Taylor, S.S.; Trewhella, J.
Differential effects of substrate on type I and type II PKA holoenzyme dissociation
Biochemistry
43
5629-5636
2004
Bos taurus
brenda
Wu, J.; Jones, J.M.; Nguyen-Huu, X.; Ten Eyck, L.F.; Taylor, S.S.
Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP
Biochemistry
43
6620-6629
2004
Bos taurus
brenda
Viste, K.; Kopperud, R.K.; Christensen, A.E.; Doskeland, S.O.
Substrate enhances the sensitivity of type I protein kinase a to cAMP
J. Biol. Chem.
280
13279-13284
2005
Bos taurus, Homo sapiens
brenda
Horner, T.J.; Osawa, S.; Schaller, M.D.; Weiss, E.R.
Phosphorylation of GRK1 and GRK7 by cAMP-dependent protein kinase attenuates their enzymatic activities
J. Biol. Chem.
280
28241-28250
2005
Bos taurus, Homo sapiens
brenda
Tian, L.; Coghill, L.S.; McClafferty, H.; MacDonald, S.H.; Antoni, F.A.; Ruth, P.; Knaus, H.G.; Shipston, M.J.
Distinct stoichiometry of BKCa channel tetramer phosphorylation specifies channel activation and inhibition by cAMP-dependent protein kinase
Proc. Natl. Acad. Sci. USA
101
11897-11902
2004
Bos taurus, Homo sapiens
brenda
Vigil, D.; Lin, J.H.; Sotriffer, C.A.; Pennypacker, J.K.; McCammon, J.A.; Taylor, S.S.
A simple electrostatic switch important in the activation of type I protein kinase A by cyclic AMP
Protein Sci.
15
113-121
2006
Bos taurus
brenda
Zentella de Pina, M.; Vazquez-Meza, H.; Agundis, C.; Pereyra, M.A.; Pardo, J.P.; Villalobos-Molina, R.; Pina, E.
Inhibition of cAMP-dependent protein kinase A: a novel cyclo-oxygenase-independent effect of non-steroidal anti-inflammatory drugs in adipocytes
Auton. Autacoid. Pharmacol.
27
85-92
2007
Bos taurus, Rattus norvegicus
brenda
Abu-Abed, M.; Das, R.; Wang, L.; Melacini, G.
Definition of an electrostatic relay switch critical for the cAMP-dependent activation of protein kinase A as revealed by the D170A mutant of RIalpha
Proteins
69
112-124
2007
Bos taurus
brenda
Komalavilas, P.; Penn, R.B.; Flynn, C.R.; Thresher, J.; Lopes, L.B.; Furnish, E.J.; Guo, M.; Pallero, M.A.; Murphy-Ullrich, J.E.; Brophy, C.M.
The small heat shock-related protein, HSP20, is a cAMP-dependent protein kinase substrate that is involved in airway smooth muscle relaxation
Am. J. Physiol. Lung Cell Mol. Physiol.
294
L69-L78
2008
Bos taurus
brenda
De Rasmo, D.; Panelli, D.; Sardanelli, A.M.; Papa, S.
cAMP-dependent protein kinase regulates the mitochondrial import of the nuclear encoded NDUFS4 subunit of complex I
Cell. Signal.
20
989-997
2008
Bos taurus
brenda
de Pina, M.Z.; Vazquez-Meza, H.; Pardo, J.P.; Rendon, J.L.; Villalobos-Molina, R.; Riveros-Rosas, H.; Pina, E.
Signaling the signal, cyclic AMP-dependent protein kinase inhibition by insulin-formed H2O2 and reactivation by thioredoxin
J. Biol. Chem.
283
12373-12386
2008
Bos taurus, Rattus norvegicus
brenda
Grueb, M.; Bartz-Schmidt, K.U.; Rohrbach, J.M.
Adrenergic regulation of cAMP/protein kinase A pathway in corneal epithelium and endothelium
Ophthalmic Res.
40
322-328
2008
Bos taurus
brenda
Shell, J.R.; Lawrence, D.S.
Proteolytic regulation of the mitochondrial cAMP-dependent protein kinase
Biochemistry
51
2258-2264
2012
Bos taurus
brenda
Shell, J.R.; Lawrence, D.S.
Probes of the mitochondrial cAMP-dependent protein kinase
Biochim. Biophys. Acta
1834
1359-1363
2013
Bos taurus
brenda
Byeon, I.J.; Dao, K.K.; Jung, J.; Keen, J.; Leiros, I.; Doskeland, S.O.; Martinez, A.; Gronenborn, A.M.
Allosteric communication between cAMP binding sites in the RI subunit of protein kinase A revealed by NMR
J. Biol. Chem.
285
14062-14070
2010
Bos taurus
brenda